Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:00 pm Purchase |
2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 2,997,111 9.990% |
2,997,111 (New Position) |
Filing History |
| 2023-02-14 11:59 am Purchase |
2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 2,997,111 9.990% |
2,997,111 (New Position) |
Filing History |
| 2023-02-14 11:58 am Purchase |
2022-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Armistice Capital, LLC | 5,333,951 9.990% |
5,333,951 (New Position) |
Filing History |
| 2023-02-14 11:54 am Purchase |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Armistice Capital, LLC | 2,750,000 5.010% |
2,750,000 (New Position) |
Filing History |
| 2023-02-14 11:53 am Purchase |
2022-12-31 | 13G | Addex Therapeutics Ltd ADXN |
Armistice Capital, LLC | 201,923 4.970% |
170,283 (+538.19%) |
Filing History |
| 2023-02-14 11:52 am Purchase |
2022-12-31 | 13G | Acurx Pharmaceuticals, Inc. ACXP |
Armistice Capital, LLC | 880,000 7.590% |
880,000 (New Position) |
Filing History |
| 2023-02-14 11:50 am Purchase |
2022-12-31 | 13G | Talphera, Inc. TLPH |
Armistice Capital, LLC | 864,328 9.990% |
864,328 (New Position) |
Filing History |
| 2023-02-14 11:49 am Purchase |
2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Armistice Capital, LLC | 1,106,000 6.440% |
1,106,000 (New Position) |
Filing History |
| 2023-02-10 4:28 pm Purchase |
2022-12-31 | 13G | Cyclo Therapeutics, Inc. CYTH |
Armistice Capital, LLC | 1,030,000 10.800% |
814,674 (+378.34%) |
Filing History |
| 2023-02-09 4:27 pm Purchase |
2023-02-07 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 19,928 35.400% |
1,876 (+10.39%) |
Filing History |
| 2022-09-23 1:40 pm Purchase |
2022-09-23 | 13G | Freshpet, Inc. FRPT |
Armistice Capital, LLC | 2,650,000 5.500% |
2,650,000 (New Position) |
Filing History |
| 2022-08-11 4:09 pm Sale |
2022-08-08 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 18,052 44.400% |
-0 (-0.00%) |
Filing History |
| 2022-06-21 06:08 am Unchanged |
2022-06-21 | 13G | Tenax Therapeutics, Inc. TENX |
Armistice Capital, LLC | 1,608 9.990% |
0 (Unchanged) |
Filing History |
| 2022-06-17 5:16 pm Purchase |
2022-06-10 | 13D | Tenax Therapeutics, Inc. TENX |
Armistice Capital, LLC | 1,608 9.990% |
0 (+0.02%) |
Filing History |
| 2022-05-20 4:52 pm Unchanged |
2022-05-17 | 13D | Tenax Therapeutics, Inc. TENX |
Armistice Capital, LLC | 1,608 9.990% |
0 (Unchanged) |
Filing History |
| 2022-03-15 5:16 pm Purchase |
2022-03-14 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 18,052 44.500% |
408 (+2.31%) |
Filing History |
| 2022-02-14 9:56 pm Sale |
2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
Armistice Capital, LLC | 0 0.000% |
-5,399,277 (Position Closed) |
Filing History |
| 2022-02-14 9:55 pm Sale |
2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Armistice Capital, LLC | 0 0.000% |
-2,742,000 (Position Closed) |
Filing History |
| 2022-02-14 9:54 pm Sale |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 0 0.000% |
-3,392,000 (Position Closed) |
Filing History |
| 2022-02-14 9:37 pm Purchase |
2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Armistice Capital, LLC | 800,000 5.100% |
800,000 (New Position) |
Filing History |